DT
Dio Tree
Developing a novel small molecule inhibitor for ovarian cancer treatment targeting DIO3.
About
Dio Tree Life Sciences is a biotechnology startup focused on developing a first-in-class small molecule therapy for ovarian cancer. Their innovative approach targets the enzyme DIO3, identified as a significant driver in various cancers, particularly ovarian cancer.
Technology stack
detected 2026-06-10Est. monthly stack spend~$70/mo
Emailnone
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does Dio Tree do?
Dio Tree Life Sciences is a biotechnology startup focused on developing a first-in-class small molecule therapy for ovarian cancer. Their innovative approach targets the enzyme DIO3, identified as a significant driver in various cancers, particularly ovarian cancer.
How much funding has Dio Tree raised?
Dio Tree has raised a total of $15M in funding. The most recent round on record is Seed.
Where is Dio Tree headquartered?
Dio Tree is headquartered in Cambridge, United States.
When was Dio Tree founded?
Dio Tree was founded in 2022.
What industry does Dio Tree operate in?
Dio Tree operates in Life Sciences, Oncology, Biotech, Drug Discovery, Small Molecule Inhibitor, Enzyme Inhibitor.
What is Dio Tree's current status?
Dio Tree's current operating status is: Inactive.